Asenar
.
///
Borsa
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
⌂
☀️
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
Sabitler
Temettüler
Blog
Ekip
Giriş
Çıkış
BIST Hub
›
Health Care Equipment & Supplies
› ONCSM
Research
BIST: ONCSM
ONCOSEM ONKOLOJİK SİSTEMLER SANAYİ VE TİCARET A.Ş.
BIST Main
SME
Halal
Ankara
🔔
Set Alert
⚖
Compare
Share
273.50 TRY
Source:
KAP
Market Cap
TRY
6,522,975,000 TRY
USD
$144,419,045
EUR
—
1 USD = 45.17 TRY
Current Snapshot
- 2025 Q4
P/E Ratio
42.35x
↓ vs prior period
P/B Ratio
16.03x
↓ vs prior period
Gross Margin
45.11%
Op. Margin
21.72%
↑ vs prior period
Net Margin
21.72%
↑ vs prior period
ROE
37.85%
↑ vs prior period
ROA
24.68%
Source:
KAP
Debt / Equity
0.53x
↑ vs prior period
Current Ratio
2.61x
Liquidity check
Equity Ratio
65.21%
Asset coverage
EV / EBIT
42.35x
↓ vs prior period
Op. profit proxy
EV / Sales
9.20x
↓ vs prior period
Enterprise value
Piotroski F
4/9
Neutral (4/9)
Altman Z-Score
21.37
↓ vs prior period
Safe Zone ✓
Sector Benchmarks
KGK — Tümü · 11,069 companies · FY2023 (latest available)
Sector ROE
22.0%
Net Margin
10.0%
Current Ratio
1.17x
Debt/Equity
0.73x
Earnings
— Q4 2025
Net Income YoY
(vs Q4 2024)
▲ +2400.2%
154M TRY vs 6M TRY
Revenue YoY
(vs Q4 2024)
▲ +89.3%
709M TRY vs 374M TRY
Net Income QoQ
(vs Q3 2025)
▲ +503.6%
154M TRY vs 26M TRY
Revenue QoQ
(vs Q3 2025)
▲ +35.5%
709M TRY vs 523M TRY
Latest KAP Filings
Loading filings...
Sector Peers
View all in sector →
MPARK
MLP SAĞLIK HİZMETLERİ A.Ş.
P/E 8.0
ROE 30.5%
85.0B
MEDTR
MEDİTERA TIBBİ MALZEME SANAYİ
P/E 37.6
ROE 3.3%
3.6B
LKMNH
LOKMAN HEKİM ENGÜRÜSAĞ SAĞLIK
P/E 6.2
ROE 22.2%
3.3B
SEYKM
SEYİTLER KİMYA SANAYİ A.Ş.
P/E —
ROE -4.6%
1.1B
🔒
Unlock Full Analysis
AI-powered analysis, historical charts and full financial data for all 729 BIST companies.
AI Analysis — strengths, risks & outlook
Financial Charts — revenue, margins, returns, valuation
Historical Comparison — full quarterly data table
Get Premium Access
Sign in to your account →
Have a legacy key?
Activate
AI Analysis
Financial Charts
Revenue vs Net Income (1M TRY)
Equity vs Liabilities (1M TRY)
Profit Margins (%)
Returns — ROE vs ROA (%)
Valuation — P/E vs P/B
Advanced Analytics
Profit Cascade (1M TRY)
Revenue & Net Income Growth % (vs prior period)
3-Layer Margin Analysis — Gross, Operating, Net (%)
DuPont ROE Decomposition
Debt Structure — Current Liabilities + Long-term Debt (1M TRY)
Get DCF Valuation
PREMIUM
Historical Comparison
Period
Revenue (1M TRY)
Net Income
Net Margin
ROE
ROA
D/E
P/E
P/B
2022 Q4
140,534,556
32,462,868
23.10%
31.23%
19.40%
0.61x
200.94x
62.75x
2023 Q4
240,505,946
-63,748,539
-26.51%
-27.51%
-18.84%
0.46x
N/A
28.15x
2024 Q4
374,489,372
6,160,777
1.65%
2.25%
1.61%
0.40x
N/A
23.79x
2025 Q1
167,741,811
7,530,345
4.49%
2.44%
1.77%
0.38x
216.56x
21.15x
2025 Q2
164,052,882
156,915
4.49%
2.44%
1.77%
0.38x
216.56x
21.15x
2025 Q3
155,837,246
16,767,401
2.38%
2.50%
1.72%
0.45x
400.69x
20.06x
2025 Q4
709,077,088
154,033,756
0.10%
0.05%
0.03%
0.45x
N/A
20.06x